tirzepatide nafld fatty liver disease Frontiers Eli Lilly's Tirzepatide Shows Promise

Outcome timelines vary by protocol, adherence, and clinician adjustments, and are shown here only as directional prototype content for review

Well tailor the schedule based on your symptoms, diet, age, and any medications youre on

Monitoring for Hypoglycemia As insulin resistance improves, hypoglycemia (low blood sugar) can become a concern, particularly for patients on insulin or sulfonylureas: Symptoms: Shakiness, sweating, confusion, rapid heartbeat, dizziness, hunger

There is considerable interest in the potential to combine GLP-1RAs with SGLT2is because their mechanisms of action are complementary with regard to target organs, disease processes [31], and the effects seen in cardiovascular/cardiorenal outcomes trials [23,24,25,26,27,28,29, 32,33,34,35,36]